Lv4
410 积分 2022-06-30 加入
Atrial fibrillation
1个月前
已完结
Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis
2个月前
已完结
Safety and efficacy of direct oral anticoagulants in geriatric patients with non-valvular atrial fibrillation: A single-center retrospective study
2个月前
已关闭
Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study
2个月前
已完结
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach
2个月前
已关闭
Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes
2个月前
已完结
Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
2个月前
已关闭
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach
2个月前
已关闭
Long-Term Clinical Outcomes of Underdosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Atrial Flutter
2个月前
已完结
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)
2个月前
已完结
皖公网安备34019202002308
